{"id":"https://openalex.org/W4367302941","doi":"https://doi.org/10.1212/wnl.0000000000203125","title":"An Interim Analysis of Efficacy and Safety Data in Black and Hispanic Patients With Multiple Sclerosis Receiving Ocrelizumab Treatment in the CHIMES Trial (S31.006)","display_name":"An Interim Analysis of Efficacy and Safety Data in Black and Hispanic Patients With Multiple Sclerosis Receiving Ocrelizumab Treatment in the CHIMES Trial (S31.006)","publication_year":2023,"publication_date":"2023-04-25","ids":{"openalex":"https://openalex.org/W4367302941","doi":"https://doi.org/10.1212/wnl.0000000000203125"},"language":"en","primary_location":{"id":"doi:10.1212/wnl.0000000000203125","doi":"https://doi.org/10.1212/wnl.0000000000203125","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.0000000000203125","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5048419324","display_name":"Evanthia Bernitsas","orcid":"https://orcid.org/0000-0001-9382-1008","observed_orcids":["https://orcid.org/0000-0001-9382-1008"]},"institutions":[{"id":"https://openalex.org/I185443292","display_name":"Wayne State University","ror":"https://ror.org/01070mq45","country_code":"US","type":"education","lineage":["https://openalex.org/I185443292"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Evanthia Bernitsas","raw_affiliation_strings":["Wayne State University School of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wayne State University School of Medicine","institution_ids":["https://openalex.org/I185443292"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076423610","display_name":"Anthony T. Reder","orcid":"https://orcid.org/0000-0002-6423-1495","observed_orcids":["https://orcid.org/0000-0002-6423-1495"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anthony Reder","raw_affiliation_strings":["University of Chicago Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Chicago Medicine","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065968463","display_name":"Angel R. Chinea","orcid":"https://orcid.org/0000-0002-2354-4911","observed_orcids":["https://orcid.org/0000-0002-2354-4911"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Angel Chinea","raw_affiliation_strings":["San Juan MS Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"San Juan MS Center","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000507198","display_name":"Craig Herrman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Craig Herrman","raw_affiliation_strings":["JWM Neurology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"JWM Neurology","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Barbara O\u2019Brien","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1286908927","display_name":"Baptist Memorial Hospital","ror":"https://ror.org/05xtj6g89","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1286908927"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Barbara O\u2019Brien","raw_affiliation_strings":["Baptist Memorial Hospital-Collierville"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Baptist Memorial Hospital-Collierville","institution_ids":["https://openalex.org/I1286908927"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039597406","display_name":"Richard A. Sater","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1313334418","display_name":"Cone Health","ror":"https://ror.org/03jeg4p28","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1313334418"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard Sater","raw_affiliation_strings":["Cone Health Medical Group"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cone Health Medical Group","institution_ids":["https://openalex.org/I1313334418"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063222574","display_name":"Lilyana Amezcua","orcid":"https://orcid.org/0000-0003-1542-7819","observed_orcids":["https://orcid.org/0000-0003-1542-7819"]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lilyana Amezcua","raw_affiliation_strings":["Keck School of Medicine, University of Southern California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Keck School of Medicine, University of Southern California","institution_ids":["https://openalex.org/I1174212"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080632445","display_name":"Mitzi Joi Williams","orcid":"https://orcid.org/0000-0001-6979-1101","observed_orcids":["https://orcid.org/0000-0001-6979-1101"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mitzi Williams","raw_affiliation_strings":["Joi Life Wellness MS Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Joi Life Wellness MS Center","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062246223","display_name":"Gregory F. Wu","orcid":"https://orcid.org/0000-0003-3588-0637","observed_orcids":["https://orcid.org/0000-0003-3588-0637","https://orcid.org/0000-0002-5434-3557"]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gregory Wu","raw_affiliation_strings":["Washington University in St Louis"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Washington University in St Louis","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068705235","display_name":"Timothy K. Vartanian","orcid":"https://orcid.org/0000-0001-9471-1855","observed_orcids":["https://orcid.org/0000-0001-9471-1855","https://orcid.org/0000-0002-1794-9963"]},"institutions":[{"id":"https://openalex.org/I205783295","display_name":"Cornell University","ror":"https://ror.org/05bnh6r87","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295"]},{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Timothy Vartanian","raw_affiliation_strings":["Brain and Mind Research Institute, Weill Cornell Medicine, Cornell University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brain and Mind Research Institute, Weill Cornell Medicine, Cornell University","institution_ids":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018367518","display_name":"Jinglan Pei","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jinglan Pei","raw_affiliation_strings":["Genentech, Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech, Inc","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083786388","display_name":"Juan Acosta","orcid":"https://orcid.org/0000-0002-4702-0477","observed_orcids":["https://orcid.org/0000-0002-4702-0477"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Juan Acosta","raw_affiliation_strings":["Genentech, Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech, Inc","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109079767","display_name":"Nancy L. Monson","orcid":"https://orcid.org/0000-0002-7175-7700","observed_orcids":["https://orcid.org/0000-0002-7175-7700"]},"institutions":[{"id":"https://openalex.org/I867280407","display_name":"The University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I867280407"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nancy Monson","raw_affiliation_strings":["University of Texas Southwestern"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas Southwestern","institution_ids":["https://openalex.org/I867280407"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":10,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.07264218,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"100","issue":"17_supplement_2","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11827","display_name":"Polyomavirus and related diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ocrelizumab","display_name":"ocrelizumab","score":0.9290000200271606},{"id":"https://openalex.org/keywords/relapsing-multiple-sclerosis","display_name":"relapsing multiple sclerosis","score":0.9760000109672546},{"id":"https://openalex.org/keywords/black-patients","display_name":"Black patients","score":0.9470000267028809},{"id":"https://openalex.org/keywords/hispanic-patients","display_name":"Hispanic patients","score":0.9990000128746033},{"id":"https://openalex.org/keywords/no-evidence-of-disease-activity","display_name":"no evidence of disease activity","score":0.9390000104904175},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.5669999718666077},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.7210000157356262},{"id":"https://openalex.org/keywords/infusion-related-reactions","display_name":"infusion reactions","score":0.75},{"id":"https://openalex.org/keywords/underrepresentation-in-clinical-trials","display_name":"underrepresentation in clinical trials","score":0.7710000276565552},{"id":"https://openalex.org/keywords/racial-and-ethnic-diversity","display_name":"racial and ethnic diversity","score":0.42800000309944153},{"id":"https://openalex.org/keywords/b-cell-depletion-therapy","display_name":"B-cell depletion therapy","score":0.5180000066757202},{"id":"https://openalex.org/keywords/expanded-disability-status-scale","display_name":"Expanded Disability Status Scale","score":0.6489999890327454},{"id":"https://openalex.org/keywords/gadolinium-enhancing-lesions","display_name":"gadolinium-enhancing lesions","score":0.7559999823570251},{"id":"https://openalex.org/keywords/t2-lesion-volume","display_name":"T2 lesion volume","score":0.9559999704360962},{"id":"https://openalex.org/keywords/disease-modifying-therapy","display_name":"disease-modifying therapy","score":0.4959999918937683}],"concepts":[{"id":"https://openalex.org/C2778843634","wikidata":"https://www.wikidata.org/wiki/Q2013780","display_name":"Ocrelizumab","level":4,"score":0.8393468856811523},{"id":"https://openalex.org/C2780640218","wikidata":"https://www.wikidata.org/wiki/Q8277","display_name":"Multiple sclerosis","level":2,"score":0.7474116086959839},{"id":"https://openalex.org/C2776957806","wikidata":"https://www.wikidata.org/wiki/Q4895105","display_name":"Interim","level":2,"score":0.7328693270683289},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7296838164329529},{"id":"https://openalex.org/C61943457","wikidata":"https://www.wikidata.org/wiki/Q6046661","display_name":"Interim analysis","level":3,"score":0.7239592671394348},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.48180216550827026},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2886558473110199},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.0649787187576294},{"id":"https://openalex.org/C95457728","wikidata":"https://www.wikidata.org/wiki/Q309","display_name":"History","level":0,"score":0.05389663577079773},{"id":"https://openalex.org/C166957645","wikidata":"https://www.wikidata.org/wiki/Q23498","display_name":"Archaeology","level":1,"score":0.0},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.0},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1212/wnl.0000000000203125","doi":"https://doi.org/10.1212/wnl.0000000000203125","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.0000000000203125","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"},{"id":"https://metadata.un.org/sdg/10","score":0.7307999730110168,"display_name":"Reduced inequalities"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4394599727","https://openalex.org/W7171803328","https://openalex.org/W6941212238","https://openalex.org/W4389404666","https://openalex.org/W4379988279","https://openalex.org/W4316506655","https://openalex.org/W3163429918","https://openalex.org/W4409222258","https://openalex.org/W4406116287","https://openalex.org/W4389449298"],"abstract_inverted_index":{"Objective:":[0],"To":[1],"analyze":[2],"the":[3,156,305,324,357,375,394,412,437,461,530,548,566,585,603,621,640,659,679,698,717,776,794,813,831,850,871,925,943,961,979,1064,1083,1102,1121,1139,1157,1176,1194,1214,1232,1256,1280,1304,1329,1353,1378,1402,1428,1452,1472,1493,1513,1533,1552,1571,1627,1651,1675,1702,1723,1741,1759,1777,1803,1841,1860,1879],"interim":[4,130,170,282],"efficacy":[5],"and":[6,15,25,33,65,70,93,115,179,195,215,238,269,294],"safety":[7],"data":[8,131,287],"for":[9,121,288,309,315,328,334,361,366,379,384,398,403,416,427,441,452,465,477,534,539,552,557,570,575,589,594,607,612,625,631,644,650,663,669,683,689,702,708,721,727,780,785,798,803,817,822,835,841,854,860,875,881,929,934,947,952,965,970,983,994,1068,1073,1087,1092,1106,1111,1125,1130,1143,1148,1161,1166,1180,1185,1198,1203,1218,1223,1236,1247,1260,1271,1284,1295,1308,1319,1333,1344,1357,1368,1382,1393,1406,1417,1432,1443,1456,1462,1476,1482,1497,1503,1517,1523,1537,1543,1556,1562,1575,1581,1631,1642,1655,1666,1679,1691,1706,1712,1727,1732,1745,1750,1763,1768,1781,1792,1807,1813,1827,1845,1850,1864,1869,1883,1889],"ocrelizumab":[10],"(OCR)":[11],"treatment":[12,290],"in":[13,30,68,304,323,356,374,393,411,436,460,529,547,565,584,602,620,639,658,678,697,716,775,793,812,830,849,870,924,942,960,978,1063,1082,1101,1120,1138,1156,1175,1193,1213,1231,1255,1279,1303,1328,1352,1377,1401,1427,1451,1471,1492,1512,1532,1551,1570,1626,1650,1674,1701,1722,1740,1758,1776,1802,1840,1859,1878],"Black":[14,24,69,86,178,293],"Hispanic":[16,26,71,295],"patients":[17,27,35,138,159,174,198,250,260],"with":[18,124,137,251,1608],"relapsing":[19],"multiple":[20],"sclerosis":[21],"(pwRMS).":[22],"Background:":[23],"are":[28],"underrepresented":[29],"MS":[31,39,209,1007,1610,1794],"trials,":[32],"these":[34],"may":[36],"have":[37],"higher":[38],"incidence,":[40],"faster":[41],"disease":[42,63,151],"progression":[43,49],"and/or":[44],"an":[45,125,468,1682,1709,1830,1898],"increased":[46],"risk":[47],"of":[48,101,150,158,197,211,249,307,326,338,349,359,377,396,414,439,463,481,492,503,514,532,550,568,587,605,623,642,661,681,700,719,731,742,754,778,796,815,833,852,873,886,897,908,927,945,963,981,998,1011,1022,1033,1047,1066,1085,1104,1123,1141,1159,1178,1196,1216,1234,1258,1282,1306,1331,1355,1380,1404,1430,1454,1474,1495,1515,1535,1554,1573,1629,1653,1677,1693,1704,1714,1725,1743,1761,1779,1805,1832,1843,1862,1881,1908,1919],"to":[50,61,767,1594,1615,1819,1941],"disability":[51],"vs":[52],"White":[53],"patients.":[54,72,296],"The":[55,129,144,247,280,336,347,479,490,501,512,729,740,752,884,895,906,996,1009,1020,1031,1045,1906,1917],"CHIMES":[56,281],"trial":[57],"(NCT04377555)":[58],"was":[59,133,147,186,191,220,229,235,243,253],"designed":[60],"evaluate":[62],"activity":[64,152],"OCR":[66,110,142,289],"response":[67,291],"Design/Methods:":[73],"This":[74,169],"prospective,":[75],"open-label,":[76],"single-arm,":[77],"Phase":[78],"IV":[79],"study":[80],"included":[81,172],"pwRMS":[82],"who":[83,139],"self-identified":[84],"as":[85,155,363,381,400,467,536,554,572,591,609,782,800,819,931,949,967,1070,1089,1108,1127,1145,1163,1182,1200,1220,1603,1681,1708,1729,1747,1765,1829,1847,1866],"or":[87,422,447,472,989,1242,1266,1290,1314,1339,1363,1388,1412,1438,1618,1637,1661,1686,1787,1897,1938],"Hispanic,":[88],"were":[89,199],"aged":[90],"18\u201365":[91],"years":[92,214],"had":[94,202,265,271],"Expanded":[95],"Disability":[96],"Status":[97],"Scale":[98],"(EDSS)":[99],"scores":[100],"0\u20135.5":[102],"points":[103],"at":[104,165],"screening.":[105],"Patients":[106,201],"received":[107,301,320,342,353,371,390,408,433,457,485,496,507,518,526,544,562,581,599,617,636,655,675,694,713,735,746,758,772,790,809,827,846,867,890,901,912,921,939,957,975,1002,1015,1026,1037,1051,1060,1079,1098,1117,1135,1153,1172,1190,1210,1228,1252,1276,1300,1325,1349,1374,1398,1424,1448,1468,1489,1509,1529,1548,1567,1587,1623,1647,1671,1698,1719,1737,1755,1773,1799,1824,1837,1856,1875,1895,1912,1923,1931],"two":[108],"300-mg":[109],"infusions":[111],"14":[112],"days":[113],"apart,":[114],"600":[116],"mg":[117],"every":[118],"24":[119],"weeks":[120],"1":[122],"year,":[123],"optional":[126],"3-year":[127],"extension.":[128],"cutoff":[132],"March":[134],"30,":[135],"2022,":[136],"completed":[140],"1-year":[141],"treatment.":[143],"primary":[145],"outcome":[146],"no":[148],"evidence":[149],"(NEDA),":[153],"defined":[154],"proportion":[157,248],"free":[160],"from":[161,345,488,499,510,521,738,749,761,893,904,915,1005,1018,1029,1040,1054,1590,1901,1915,1926,1935],"a":[162,203,266,272,312,331,364,382,401,419,444,537,555,573,592,610,628,647,666,686,705,724,783,801,820,838,857,878,932,950,968,986,1071,1090,1109,1128,1146,1164,1183,1201,1221,1239,1263,1287,1311,1336,1360,1385,1409,1435,1459,1479,1500,1520,1540,1559,1578,1591,1600,1604,1634,1658,1730,1748,1766,1784,1810,1848,1867,1886,1936],"protocol-defined":[163],"event":[164],"Week":[166],"48.":[167],"Results:":[168],"analysis":[171,283],"49/182":[173],"enrolled,":[175],"36":[176],"(73.5%)":[177],"13":[180],"(26.5%)":[181],"Hispanic.":[182],"Mean":[183],"(SD)":[184,205,226],"age":[185],"33.3":[187],"(8.1)":[188],"years,":[189],"weight":[190],"90.6":[192],"(23.9)":[193],"kg":[194],"85.7%":[196],"female.":[200],"mean":[204,225],"time":[206,216],"since":[207,217],"first":[208],"symptoms":[210],"3.8":[212],"(5.1)":[213],"RMS":[218],"diagnosis":[219],"1.6":[221],"(3.4)":[222],"years.":[223],"Baseline":[224],"EDSS":[227],"score":[228],"2.5":[230,236],"(1.5),":[231],"Gd-enhancing":[232],"T1":[233],"lesions":[234],"(3.9)":[237],"total":[239],"T2":[240],"lesion":[241],"volume":[242],"21.7":[244],"(21.8)":[245],"cm3.":[246],"NEDA":[252],"40.8%":[254],"(95%":[255],"CI":[256],"27.0%\u201355.8%).":[257],"Overall,":[258],"38":[259],"experienced":[261],"\u22651":[262],"AE,":[263],"3":[264],"serious":[267],"AE":[268],"22":[270],"non-serious":[273],"infusion-related":[274],"reaction.":[275],"No":[276],"deaths":[277],"occurred.":[278],"Conclusions:":[279],"provides":[284],"essential":[285],"preliminary":[286],"among":[292],"Disclosure:":[297],"Dr.":[298,317,339,350,368,387,405,430,454,482,493,504,515,523,541,559,578,596,614,633,652,672,691,710,732,743,755,763,769,787,806,824,843,864,887,898,909,918,936,954,972,999,1012,1023,1034,1048,1057,1076,1095,1114,1132,1150,1169,1187,1207,1225,1249,1273,1297,1322,1346,1371,1395,1421,1445,1465,1486,1506,1526,1545,1564,1584,1597,1620,1644,1668,1695,1716,1734,1752,1770,1796,1821],"Bernitsas":[299,318,340],"has":[300,319,341,352,370,389,407,432,456,484,495,506,517,525,543,561,580,598,616,635,654,674,693,712,734,745,757,765,771,789,808,826,845,866,889,900,911,920,938,956,974,1001,1014,1025,1036,1050,1059,1078,1097,1116,1134,1152,1171,1189,1209,1227,1251,1275,1299,1324,1348,1373,1397,1423,1447,1467,1488,1508,1528,1547,1566,1586,1599,1622,1646,1670,1697,1718,1736,1754,1772,1798,1817,1823,1836,1855,1874,1894,1911,1922,1930],"personal":[302,321,354,372,391,409,434,458,527,545,563,582,600,618,637,656,676,695,714,773,791,810,828,847,868,922,940,958,976,1061,1080,1099,1118,1136,1154,1173,1191,1211,1229,1253,1277,1301,1326,1350,1375,1399,1425,1449,1469,1490,1510,1530,1549,1568,1624,1648,1672,1699,1720,1738,1756,1774,1800,1825,1838,1857,1876],"compensation":[303,322,355,373,392,410,435,459,528,546,564,583,601,619,638,657,677,696,715,774,792,811,829,848,869,923,941,959,977,1062,1081,1100,1119,1137,1155,1174,1192,1212,1230,1254,1278,1302,1327,1351,1376,1400,1426,1450,1470,1491,1511,1531,1550,1569,1625,1649,1673,1700,1721,1739,1757,1775,1801,1826,1839,1858,1877],"range":[306,325,358,376,395,413,438,462,531,549,567,586,604,622,641,660,680,699,718,777,795,814,832,851,872,926,944,962,980,1065,1084,1103,1122,1140,1158,1177,1195,1215,1233,1257,1281,1305,1330,1354,1379,1403,1429,1453,1473,1494,1514,1534,1553,1572,1628,1652,1676,1703,1724,1742,1760,1778,1804,1842,1861,1880],"$500-$4,999":[308,464,1179,1381,1475,1654,1705,1780,1844,1863,1882],"serving":[310,329,362,380,399,417,442,466,535,553,571,590,608,626,645,664,684,703,722,781,799,818,836,855,876,930,948,966,984,1069,1088,1107,1126,1144,1162,1181,1199,1219,1237,1261,1285,1309,1334,1358,1383,1407,1433,1457,1477,1498,1518,1538,1557,1576,1632,1656,1680,1707,1728,1746,1764,1782,1808,1828,1846,1865,1884],"on":[311,330,418,443,627,646,665,685,704,723,837,856,877,985,1238,1262,1286,1310,1335,1359,1384,1408,1434,1458,1478,1499,1519,1539,1558,1577,1633,1657,1783,1809,1885],"Speakers":[313,332,629,648,667,687,706,725,839,858,879,1460,1480,1501,1521,1541,1560,1579,1811,1887],"Bureau":[314,333,630,649,668,688,707,726,840,859,880,1461,1481,1502,1522,1542,1561,1580,1812,1888],"Janssen@Janssen.":[316],"$5,000-$9,999":[327,360,378,779,797,816,946,964,1160,1197,1217,1356,1405,1431,1496,1536,1555,1574,1762],"Biogen.":[335,823,842,894,953,1296,1667,1733,1814],"institution":[337,348,480,491,502,513,730,741,753,885,896,907,997,1010,1021,1032,1046,1907,1918],"research":[343,486,497,508,519,736,747,759,891,902,913,1003,1016,1027,1038,1052,1913,1924],"support":[344,487,498,509,520,737,748,760,892,903,914,1004,1017,1028,1039,1053,1914,1925],"Roche/Genentech.":[346],"Reder":[351,369,388,406,431,455,483,494,505,516],"Consultant":[365,383,402,538,556,574,593,611,784,802,821,933,951,969,1072,1091,1110,1129,1147,1165,1184,1202,1222,1731,1749,1767,1849,1868],"genentech.":[367,453,489,595,995],"biogen":[385],".":[386,751],"$10,000-$49,999":[397,415,440,533,551,569,588,606,624,643,662,682,701,720,834,853,874,928,982,1067,1086,1105,1124,1142,1235,1259,1283,1307,1332,1455,1516,1726,1744,1806],"serono.":[404,511,577,671,935],"Scientific":[420,445,987,1240,1264,1288,1312,1337,1361,1386,1410,1436,1635,1659,1785],"Advisory":[421,446,474,988,1241,1265,1289,1313,1338,1362,1387,1411,1437,1636,1660,1688,1786],"Data":[423,448,990,1243,1267,1291,1315,1340,1364,1389,1413,1439,1638,1662,1788],"Safety":[424,449,991,1244,1268,1292,1316,1341,1365,1390,1414,1440,1639,1663,1789],"Monitoring":[425,450,992,1245,1269,1293,1317,1342,1366,1391,1415,1441,1640,1664,1790],"board":[426,451,993,1246,1270,1294,1318,1343,1367,1392,1416,1442,1641,1665,1791],"NK":[428],"max.":[429],"Editor,":[469,471,1683,1685],"Associate":[470,1684],"Editorial":[473,1687],"Board":[475,1606,1689],"Member":[476,1607,1690],"medlink.":[478],"biogen.":[500,558,632],"novartis.":[522,540],"Chinea":[524,542,560,579,597,615,634,653,673,692,711],"emd":[576,670],"sanofi.":[613,690],"Novartis.":[651,762,971,1272,1769],"Genentech.":[709,739,1019,1131,1248,1544,1751,1833],"allergan.":[728],"Herrman":[733,744,756],"Merck":[750],"O\u2019Brien":[764],"nothing":[766,1818],"disclose.":[768,1820],"Sater":[770,788,807,825,844,865,888,899,910],"Hoffman-LaRoche.":[786],"TG":[804,1167,1369],"Therapeutics.":[805,1168,1370,1871],"Bristol":[861,1041,1204,1418,1483],"Myers":[862,1042,1205,1419],"Squibb.":[863,1206,1420,1485],"EMD":[882,916,1112,1320,1524,1890],"Serono.":[883,917,1113,1321,1525,1891],"Roche.":[905],"Amezcua":[919,937,955,973,1000,1013,1024,1035,1049],"National":[1006,1605,1609],"Society.":[1008],"Medday.":[1030],"Squibb":[1043],"Foundation.":[1044],"NIH":[1055],"NINDS.":[1056],"Williams":[1058,1077,1096,1115,1133,1151,1170,1188,1208,1226,1250,1274,1298,1323,1347,1372,1396,1422,1446,1466,1487,1507,1527,1546,1565,1585,1598],"Biogen":[1074,1463],"Idec.":[1075,1464],"Novartis":[1093,1504],"Pharmaceuticals.":[1094,1505],"Genzyme.":[1149,1345,1583],"Alexion.":[1186,1394],"Janssen.":[1224,1444,1563],"Meyers":[1484],"Sanofi":[1582],"publishing":[1588],"royalties":[1589],"publication":[1592],"relating":[1593,1940],"health":[1595,1942],"care.":[1596,1943],"non-compensated":[1601],"relationship":[1602],"Society":[1611],"that":[1612],"is":[1613],"relevant":[1614],"AAN":[1616],"interests":[1617,1934],"activities.":[1619],"Wu":[1621,1645,1669,1696],"$0-$499":[1630,1678],"Progentec.":[1643],"Journal":[1692],"Neuroimmunology.":[1694],"Expert":[1710],"Witness":[1711],"Department":[1713],"Justice.":[1715],"Vartanian":[1717,1735,1753,1771,1797],"Tisch":[1793],"Center.":[1795],"Jinglan":[1815],"Pei":[1816],"Acosta":[1822],"employee":[1831],"Nancy":[1834,1853,1872,1892,1909,1920,1928],"Monson":[1835,1854,1873,1893,1910,1921,1929],"Genentech,":[1851],"Inc..":[1852],"Horizon":[1870],"stock":[1896],"ownership":[1899],"interest":[1900],"TGM":[1902],"Life":[1903],"Sciences,":[1904],"LLC.":[1905],"NIH.":[1916],"DOD.":[1927],"intellectual":[1932],"property":[1933],"discovery":[1937],"technology":[1939]},"counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2023-04-29T00:00:00"}